Short-term Outcomes of Urgent Transcatheter Aortic Valve Replacement in Symptomatic Aortic Stenosis That Requires Emergency Hospital Admission
- PMID: 36725049
- PMCID: PMC10518535
- DOI: 10.2169/internalmedicine.0638-22
Short-term Outcomes of Urgent Transcatheter Aortic Valve Replacement in Symptomatic Aortic Stenosis That Requires Emergency Hospital Admission
Abstract
Objective This study retrospectively compared the outcomes of emergently admitted patients with aortic stenosis (AS) with or without urgent transcatheter aortic valve replacement (TAVR). Methods Patients hospitalized between February 2015 and December 2019 for symptomatic AS were retrospectively analyzed by comparing the received conservative management [continued medical therapy with or without elective surgical transcatheter replacement (SAVR) or TAVR scheduled after the index hospitalization] and urgent TAVR (TAVR during the index hospitalization). Results The cohort comprised 114 patients with symptomatic AS who required emergency admission. Urgent TAVR was performed for 37 patients, while conservative management was provided for 77 patients, including 1 who received urgent SAVR. Urgent TAVR was more likely to be performed in patients with a history of hospitalization for heart failure, high New York Heart Association class scores, a lower clinical frailty scale at admission, and a high aortic valve peak velocity (p=0.01, p<0.001, p<0.01 and p=0.02, respectively). Kaplan-Meier analyses with log-rank test revealed favorable outcomes of urgent TAVR in all-cause mortality and cardiovascular events within 60 days of admission (p<0.01, p<0.01, respectively). Conclusion Urgent TAVR had better short-term outcomes in patients with symptomatic AS who required emergency hospital admission than conservative management. When considering urgent TAVR, patients with typical heart failure symptoms due to AS with a history of heart failure hospitalization and relatively little frailty can be selected.
Keywords: aortic stenosis; outcome; transcatheter aortic valve replacement.
Conflict of interest statement
Yohei Ohno: proctor, Medtronic. Norihiko Kamioka: proctor, Edwards Life Sciences.
Figures


Comment in
-
Urgent Transcatheter Aortic Valve Replacement for Acutely Decompensated Severe Aortic Stenosis.Intern Med. 2023 Sep 1;62(17):2449-2450. doi: 10.2169/internalmedicine.1416-22. Epub 2023 Feb 1. Intern Med. 2023. PMID: 36725033 Free PMC article. No abstract available.
References
-
- Hu K, Wan Y, Hong T, et al. . Therapeutic decision-making for elderly patients with symptomatic severe valvular heart diseases. Int Heart J 57: 434-440, 2016. - PubMed
-
- Bach DS, Siao D, Girard SE, et al. . Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes 2: 533-539, 2009. - PubMed
-
- Mack MJ, Leon MB, Thourani VH, et al. . Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380: 1695-1705, 2019. - PubMed
-
- Popma JJ, Deeb GM, Yakubov SJ, et al. . Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380: 1706-1715, 2019. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials